Activatable Sulfur Dioxide Nanosonosensitizer Enables Precisely Controllable Sono‐Gaseous Checkpoint Trimodal Therapy for Orthotopic Hepatocellular Carcinoma
Advanced Science · 2025
DOI: 10.1002/advs.202409442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jing Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Huashan Hospital, Fudan University, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sulfur Dioxide, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science Fund for Excellent Young Scholars, National Natural Science Fund for Young Scholars.
Abstract (Originalsprache)
Immune checkpoint blockade (ICB) is combined with sonodynamic therapy (SDT) to increase response rates and enhance anticancer efficacy. However, the “always on” property of most sonosensitizers in reducing tumor microenvironment (TME) compromises the therapeutic outcome of sonoimmunotherapy and exacerbates adverse side effects. Precisely controllable strategies combining sulfur dioxide (SO 2 ) gas therapy with cancer immunotherapy can address these issues but remain lacking. Herein an “activatable SO 2 nanosonosensitizer” for precise sono‐gaseous checkpoint trimodal therapy of orthotopic hepatocellular carcinoma (HCC) is reported, whose full activity is initiated by ultrasound (US) irradiation in the reducing TME. This “activatable SO 2 nanosonosensitizer,” Aza‐DNBS nanoparticles (NPs), are established by self‐assembling Aza‐boron‐dipyrromethene based sonosensitizer molecules and 2,4‐dinitrobenzenesulfonate (DNBS)‐caged SO 2 prodrug. The activity of Aza‐DNBS NPs is initially silenced, and the sonodynamic, gaseous, and immunosuppressive TME reprogramming activities are precisely awakened under US irradiation. Due to the glutathione‐responsiveness of Aza‐DNBS NPs, Aza‐DNBS NPs can generate large amounts of SO 2 for gas therapy‐enhanced SDT, which triggers robust immunogenic cell death activation and reprogramming of the immunosuppressive TME, thereby significantly suppressing orthotopic tumor growth and delaying lung metastasis. Thus, this study represents a strategy for designing a generic nanoplatform for precisely combined immunotherapy of orthotopic HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 2000444, China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
- National Science Fund for Excellent Young Scholars
- National Natural Science Fund for Young Scholars
- Shanghai Science and Technology Development Fund
- Shanghai Shuguang Program
- Shanghai Science and Technology Program
- Shanghai Rising-Star Program
- Key Science and Technology Research and Development Projects of Jiangxi Province
Zitieren
APA
Liang, J., Cheng, G., Qiu, L., Xue, L., Xu, H., Qiao, X., Guo, N., Xiang, H., Chen, Y., & Ding, H. (2025). Activatable Sulfur Dioxide Nanosonosensitizer Enables Precisely Controllable Sono‐Gaseous Checkpoint Trimodal Therapy for Orthotopic Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202409442
Vancouver
Liang J, Cheng G, Qiu L, Xue L, Xu H, Qiao X, et al. Activatable Sulfur Dioxide Nanosonosensitizer Enables Precisely Controllable Sono‐Gaseous Checkpoint Trimodal Therapy for Orthotopic Hepatocellular Carcinoma. Advanced Science. 2025. doi:10.1002/advs.202409442
BibTeX
@article{Liang2025,
author = {Liang, Jing and Cheng, Guangwen and Qiu, Luping and Xue, Liyun and Xu, Huning and Qiao, Xiaohui and Guo, Na and Xiang, Huijing and Chen, Yu and Ding, Hong},
title = {Activatable Sulfur Dioxide Nanosonosensitizer Enables Precisely Controllable Sono‐Gaseous Checkpoint Trimodal Therapy for Orthotopic Hepatocellular Carcinoma},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409442}
}
EUVIMED